Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast
Rowland Noakes Queensland Institute of Dermatology, Greenslopes Private Hospital Campus, Greenslopes, QLD, Australia Background: Scleroderma is traditionally managed with immunomodulatory agents such as methotrexate, mycophenolate mofetil and corticosteroids. There are anecdotal reports for, and the...
Saved in:
Main Author: | Noakes R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tranilast Can be a Useful Addition to the Limited Anti-Epidermolysis Bullosa Weaponry
by: Mohammad Mahdi Parvizi, et al.
Published: (2017) -
Successful Treatment of Annular Elastolytic Giant Cell Granuloma with Tranilast and Topical Glucocorticoid under the Strict Restriction of Sun Exposure
by: Hidetoshi Takahashi, et al.
Published: (2015) -
Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells
by: Seok Hui Kang, et al.
Published: (2019) -
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway
by: Kato M, et al.
Published: (2020) -
Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
by: Toshiyuki Shimizu, et al.
Published: (2005)